Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — 9M 2022 Earnings Presentation
12 slides from Novonesis A/s Class B's earnings presentation, Nov 4, 2022
Slide 1: Conference call 9M 2022
Conference call 9M 2022 November 3, 2022
Slide 2: Forward Looking Statement
Disclaimer Forward Looking Statement This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limite
Slide 3: Full-year upgrade from October 7 confirmed by a strong start to Q4
Full-year upgrade from October 7 confirmed by a strong start to Q4 Sales and financial performance • Organic 9M sales growth y/y: 9% (Q3 y/y: 6%). Reported DKK sales growth: 17% (Q3 y/y: 2022 2022 16%). outlook outlook • Broad-based and strong performance across the business. Slightly positive prici
Slide 4: Household Care
Household Care Performance in line with expectations 2022 expectations • Organic 9M sales growth y/y: 0% (Q3 y/y: -1%). • Growth will be driven by penetration in emerging markets, primarily within the laundry category. • Growth driven by emerging markets, from both Latin America and Asia Pacific and
Slide 5: Food, Beverages & Human Health
Food, Beverages & Human Health 2022 expectations Solid performance with broad-based growth • Organic sales growth outlook is maintained in the ‘low • Organic 9M sales growth y/y: 8% (Q3 y/y: 2%). teens’ and expected to be driven by all segments with strong growth in the fourth quarter. • Growth in F
Slide 6: Bioenergy
Bioenergy Strong performance across applications and regions 2022 expectations • Organic 9M sales growth y/y: 26% (Q3 y/y: 32%). • Full-year organic sales growth indication raised from ‘mid-teens’ to ‘high-teens’. • Growth mainly driven by innovation in North America, supported by recovering U.S. et
Slide 7: Grain & Tech Processing
Grain & Tech Processing Strong performance led by Grain 2022 expectations • Organic 9M sales growth y/y: 11% (Q3 y/y: 7%). • Growth in Grain led mainly by strong underlying end-market demand, market penetration in • Double-digit growth in Grain driven strong underlying end- vegetable oil processing
Slide 8: Agriculture, Animal Health & Nutrition
Agriculture, Animal Health & Nutrition Solid 9M performance driven by Animal Health & Nutrition 2022 expectations • Organic 9M sales growth y/y: 7% (Q3 y/y: -7%). • Growth in Animal Health & Nutrition will primarily be driven by innovation and solid end-market • Performance was solid and driven by s
Slide 9: Financial results 9M
Financial results 9M • Organic sales growth 9M y/y: 9%; DKK sales 17% y/y. • Gross margin at 54.9%; 3.3pp lower than last year due to higher input, energy and logistics costs as well as less favorable Q3 product mix due to timing, partly mitigated by productivity improvements, operational leverage a
Slide 10: Financial outlook 2022
Financial outlook 2022 • Strong start to Q4 confirms full-year outlook of 8-9% organic sales growth with an additional 9% in Danish kroner. Pricing and better mix becoming a stronger component in the fourth quarter. • EBIT margin outlook maintained at 26% to 27%, including the non-cash accounting ga
Slide 11: Summary
Summary Strong start to Q4 confirms full-year outlook. Capitalizing on additional growth opportunities • Strong and broad-based growth with performance upgrades throughout the year, capitalizing on additional growth opportunities when they arise. • Pricing to become a stronger contributor in Q4 and
Slide 12: Slide 12